POSPÍŠILOVÁ, Šárka, Pavlína MARVANOVÁ, Jakub TREML, Agnes M. MORICZ, Peter G. OTT, Petr MOKRÝ, Klára ODEHNALOVÁ, Ondrej ŠEDO, Alois ČÍŽEK and Josef JAMPÍLEK. Activity of N-Phenylpiperazine Derivatives Against Bacterial and Fungal Pathogens. CURRENT PROTEIN & PEPTIDE SCIENCE. Bentham Science Publishers, 2019, vol. 20, No 11, p. 1119-1129. ISSN 1389-2037. Available from: https://dx.doi.org/10.2174/1389203720666190913114041.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Activity of N-Phenylpiperazine Derivatives Against Bacterial and Fungal Pathogens
Authors POSPÍŠILOVÁ, Šárka (203 Czech Republic), Pavlína MARVANOVÁ (203 Czech Republic), Jakub TREML (203 Czech Republic), Agnes M. MORICZ (348 Hungary), Peter G. OTT (348 Hungary), Petr MOKRÝ (203 Czech Republic), Klára ODEHNALOVÁ (203 Czech Republic), Ondrej ŠEDO (203 Czech Republic, guarantor, belonging to the institution), Alois ČÍŽEK (203 Czech Republic) and Josef JAMPÍLEK (203 Czech Republic).
Edition CURRENT PROTEIN & PEPTIDE SCIENCE, Bentham Science Publishers, 2019, 1389-2037.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10608 Biochemistry and molecular biology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.520
RIV identification code RIV/00216224:14740/19:00107988
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.2174/1389203720666190913114041
UT WoS 000492730400011
Keywords in English N-phenylpiperazines; synthesis; lipophilicity; dissociation constant; antimycobacterials; antifungals; cytotoxicity
Tags CF PROT, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Michal Petr, učo 65024. Changed: 17/2/2021 13:35.
Abstract
Background: As the bacterial resistance to antibacterial chemotherapeutics is one of the greatest problems in modern medicine, efforts are made to develop new antimicrobial drugs. Compounds with a piperazine ring have proved to be promising agents against various pathogens. Objective: The aim of the study was to prepare a series of new N-phenylpiperazines and determine their activity against various pathogens. Method: Target compounds were prepared by multi-step synthesis starting from an appropriate substituted acid to an oxirane intermediate reacting with 1-(4-nitrophenyl)piperazine. Lipophilicity and pK(a) values were experimentally determined. Other molecular parameters were calculated. The inhibitory activity of the target compounds against Staphylococcus aureus, four mycobacteria strains, Bipolaris sorokiniana, and Fusarium avenaceum was tested. In vitro antiproliferative activity was determined on a THP-1 cell line, and toxicity against plant was determined using Nicotiana tabacum. Results: In general, most compounds demonstrated only moderate effects. 1-(2-Hydroxy-3-{[4-(propan-2-yloxy)benzoyl]oxy}propyl)-4-(4-nitropbenyl)piperazinediium dichloride and 1-{3-[(4-butoxybenzoyl)-oxy]-2-hydroxypropyl} -4-(4-nitrophenyl)piperazinediium dichloride showed the highest inhibition activity against M. kansasii (MIC - 15.4 and 15.0 mu M, respectively) and the latter also against M. marinum (MIC = 15.0 mu M). 1-(2-Hydroxy-3-{[4-(2-propoxyethoxy)benzoyl]oxy}propyl)-4-(4-nitrophenyl)piperazinediium dichloride had the highest activity against F. avenaceum (MIC - 14.2 mu M). All the compounds showed only insignificant toxic effects on human and plant cells. Conclusion: Ten new 1-(4-nitrophenyl)piperazine derivatives were prepared and analyzed, and their antistaphylococcal, antimycobacterial, and antifungal activities were determined. The activity against M. kansasii was positively influenced by higher lipophilicity, the electron-donor properties of substituent R and a lower dissociation constant. The exact mechanism of action will be investigated in follow-up studies.
Links
GBP206/12/G151, research and development projectName: Centrum nových přístupů k bioanalýze a molekulární diagnostice
LM2015043, research and development projectName: Česká infrastruktura pro integrativní strukturní biologii (Acronym: CIISB)
Investor: Ministry of Education, Youth and Sports of the CR
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
PrintDisplayed: 27/4/2024 01:41